Regorafenib is a synthetic compound studied as an active pharmaceutical ingredient, characterized by an aromatic, halogen-containing structure. Its crystalline forms and monohydrate have been investigated for structural properties relevant to pharmaceutical manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 755037-03-7
Regorafenib monohydrate
active pharmaceutical ingredient
Sorafenib
n.a
Sorafenib tosylate
active pharmaceutical ingredient
Flupirtine maleate
active pharmaceutical ingredient
COLCHICINE, (+)-
active pharmaceutical ingredient
Ingenol mebutate
antineoplastic agent
Fludarabine phosphate
active pharmaceutical ingredient
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Pharmaceutical reference standard intermediate
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
FNHKPVJBJVTLMP-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F